ARTICLE | Clinical News
Topamax topiramate regulatory update
April 7, 2014 7:00 AM UTC
FDA approved Topamax topiramate from Johnson & Johnson to prevent migraine headaches in adolescents ages 12-17 years. FDA said Topamax is the first drug approved for migraine prevention in the age gro...